EX-23.1 3 f10k2018ex23-1_adial.htm CONSENT OF FRIEDMAN LLP

Exhibit 23.1

 

 

  

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

  

We hereby consent to the incorporation by reference in the Registration Statements of Adial Pharmaceuticals, Inc. on Form S-8 (File No. 333-226884) of our report dated February 19, 2019 on our audits of the financial statements as of December 31, 2018 and 2017, and for each of the years in the two year period ended December 31, 2018, which was included in the Company’s Annual Report on Form 10-K filed on February 19, 2019. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern.

 

/s/ Friedman LLP

 

East Hanover, New Jersey

February 19, 2019